دورية أكاديمية

Anakinra in children and adults with Still's disease.

التفاصيل البيبلوغرافية
العنوان: Anakinra in children and adults with Still's disease.
المؤلفون: Vastert, Sebastiaan J, Jamilloux, Yvan, Quartier, Pierre, Ohlman, Sven, Koskinen, Lisa Osterling, Kullenberg, Torbjörn, Franck-Larsson, Karin, Fautrel, Bruno, Benedetti, Fabrizio de
المصدر: Rheumatology; 2019 Supplement, Vol. 58, pvi9-vi22, 14p, 3 Charts
مصطلحات موضوعية: ANTIRHEUMATIC agents, GLUCOCORTICOIDS, INTERLEUKIN-1, PATIENT safety, PROTEINS, RHEUMATOID arthritis, STILL'S disease, TREATMENT effectiveness, EARLY medical intervention, CHEMICAL inhibitors
مستخلص: Systemic juvenile idiopathic arthritis and adult-onset Still's disease are rare autoinflammatory disorders with common features, supporting the recognition of these being one disease—Still's disease—with different ages of onset. Anakinra was recently approved by the European Medicines Agency for Still's disease. In this review we discuss the reasoning for considering Still's disease as one disease and present anakinra efficacy and safety based on the available literature. The analysis of 27 studies showed that response to anakinra in Still's disease was remarkable, with clinically inactive disease or the equivalent reported for 23–100% of patients. Glucocorticoid reduction and/or stoppage was reported universally across the studies. In studies on paediatric patients where anakinra was used early or as first-line treatment, clinically inactive disease and successful anakinra tapering/stopping occurred in >50% of patients. Overall, current data support targeted therapy with anakinra in Still's disease since it improves clinical outcome, especially if initiated early in the disease course. [ABSTRACT FROM AUTHOR]
Copyright of Rheumatology is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:14620324
DOI:10.1093/rheumatology/kez350